Bioassay of teicoplanin in serum containing rifampin or a beta-lactam antibiotic
- 1 September 1989
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 12 (5) , 449-454
- https://doi.org/10.1016/0732-8893(89)90119-3
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- A sensitive bioassay for teicoplanin in serum in the presence or absence of other antibioticsDiagnostic Microbiology and Infectious Disease, 1989
- Teicoplanin in the treatment of infections by staphylococci, Clostridium difficile and other Gram-positive bacteriaJournal of Antimicrobial Chemotherapy, 1989
- Septicaemia due to Gram-positive cocci in cancer patientsJournal of Antimicrobial Chemotherapy, 1988
- Treatment of infections by staphylococci and other Gram-positive bacteria with teicoplanin: an open studyJournal of Antimicrobial Chemotherapy, 1987
- Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patientsAntimicrobial Agents and Chemotherapy, 1987
- In vitro activity and human pharmacokinetics of teicoplaninAntimicrobial Agents and Chemotherapy, 1984
- In vitro activity of teichomycin compared with those of other antibioticsAntimicrobial Agents and Chemotherapy, 1983
- Aminoglycoside uptake and mode of action—with special reference to streptomycin and gentamicinJournal of Antimicrobial Chemotherapy, 1981
- Bioassay for determination of vancomycin in the presence of rifampin or aminoglycosidesAntimicrobial Agents and Chemotherapy, 1980
- The use of -Lactamases in the Clinical LaboratoryJournal of Medical Microbiology, 1973